NCT05807880 2026-01-23
ALTER-HN005
Sun Yat-sen University
Phase 2 Active not recruiting
Clinical Trials
6 trialsNCT06892431 2025-03-25
JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer
Shanghai JMT-Bio Inc.
Phase 2 Not yet recruiting
NCT02611960 2023-07-13
Keynote-122
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00439426 2016-11-02
A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.
Hoffmann-La Roche
Phase 2 Completed
NCT02360501 2016-04-20
Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Completed
NCT00577057 2013-08-22
Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
Hospital Authority, Hong Kong
Phase NA Unknown